Twenty‐Four‐Hour Blood Pressure‐Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double‐Blind Multicenter Study
Journal of the American Heart Association · 18.04.2023 · 12 (8)
DOI: 10.1161/jaha.122.027612 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 18.04.2023. Verfasst von Kazuomi Kario und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Medicine Jichi Medical University School of Medicine Tochigi Japan. Hauptthemen laut MEDLINE: Antihypertensive Agents, East Asian People, Hypertension. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background Nighttime blood pressure (BP) and an abnormal nocturnal BP dipping profile are important cardiovascular risk factors in patients with hypertension. This post hoc analysis investigated the effects of sacubitril/valsartan on 24‐hour BP in patients with mild‐to‐moderate hypertension and in patient subgroups based on nocturnal BP dipping status. Methods and Results Data from a randomized clinical trial comparing the BP‐lowering effects of 8 weeks of treatment with sacubitril/valsartan (200 or 400 mg/d) and olmesartan (20 mg/d) in Japanese patients with mild‐to‐moderate hypertension were analyzed. The primary end point was change in 24‐hour, daytime, and nighttime BP in patient subgroups based on nocturnal BP dipping status (dipper, nondipper). Six hundred thirty‐two patients with baseline and follow‐up ambulatory BP data were included. Both sacubitril/valsartan dosages reduced 24‐hour, daytime, and nighttime systolic BP, and 24‐hour and daytime diastolic BP, to a significantly greater extent than olmesartan in the dipper and nondipper groups. However, between‐group differences in nighttime systolic BP were more significant in the nondipper group (difference [95% CI] for sacubitril/valsartan 200 and 400 mg/d versus olmesartan 20 mg/d: –4.6 [95% CI, −7.3 to −1.8] and −6.8 [95% CI, −9.5 to −4.1] mm Hg, respectively; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Department of Medicine Jichi Medical University School of Medicine Tochigi Japan.
- Department of Geriatric and General Medicine Osaka University Graduate School of Medicine Osaka Japan.
- Medical Affairs Division Novartis Pharma K.K. Tokyo Japan.
ORCID-Profile: Kazuomi Kario, Hiromi Rakugi, Daisuke Yarimizu, Yohei Morita, Shunsuke Eguchi, Kazuma Iekushi
Zitieren
APA
Kario, K., Rakugi, H., Yarimizu, D., Morita, Y., Eguchi, S., & Iekushi, K. (2023). Twenty‐Four‐Hour Blood Pressure‐Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double‐Blind Multicenter Study. Journal of the American Heart Association, 12(8). https://doi.org/10.1161/jaha.122.027612
Vancouver
Kario K, Rakugi H, Yarimizu D, Morita Y, Eguchi S, Iekushi K. Twenty‐Four‐Hour Blood Pressure‐Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double‐Blind Multicenter Study. Journal of the American Heart Association. 2023;12(8). doi:10.1161/jaha.122.027612
BibTeX
@article{Kario2023,
author = {Kario, Kazuomi and Rakugi, Hiromi and Yarimizu, Daisuke and Morita, Yohei and Eguchi, Shunsuke and Iekushi, Kazuma},
title = {Twenty‐Four‐Hour Blood Pressure‐Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double‐Blind Multicenter Study},
journal = {Journal of the American Heart Association},
year = {2023},
volume = {12},
number = {8},
doi = {10.1161/jaha.122.027612}
}
EUVIMED